Sirtuin1: A Promising Serum Protein Marker for Early Detection of Alzheimer’s Disease

Abstract

Sirtuin (SIRT) pathway has a crucial role in Alzheimer’s disease (AD). The present study evaluated the alterations in serum sirtuin1 (SIRT1) concentration in healthy individuals (young and old) and patients with AD and mild cognitive impairment (MCI). Blood samples were collected from 40 AD and 9 MCI patients as cases and 22 young healthy adults and 22 healthy elderly individuals as controls. Serum SIRT1 was estimated by Surface Plasmon Resonance (SPR), Western Blot and Enzyme Linked Immunosorbent Assay (ELISA). A significant (p<0.0001) decline in SIRT1 concentration was observed in patients with AD (2.27±0.46 ng/µl) and MCI (3.64±0.15 ng/µl) compared to healthy elderly individuals (4.82±0.4 ng/µl). The serum SIRT1 concentration in healthy elderly was also significantly lower (p<0.0001) compared to young healthy controls (8.16±0.87 ng/µl). This study, first of its kind, has demonstrated, decline in serum concentration of SIRT1 in healthy individuals as they age. In patients with AD and MCI the decline was even more pronounced, which provides an opportunity to develop this protein as a predictive marker of AD in early stages with suitable cut off values.

Increases in peripheral SIRT1: A new biological characteristic of asthma

“…levels in young adults among post-graduate students and subjects between 65 and 75 years of age; they found that the serum SIRT1 levels of the elderly subjects were much lower than those of the younger subjects. 22 SIRT1 is an anti-aging factor and has been proven to delay aging.…”

Complexity across scales: a walkthrough to linking neuro-imaging readouts to molecular processes

“…In general, their role is to maintain cellular functions and promote longevity of the cells in humans as well as other model organisms [147,148]. Sirtuins have been reported to protect the brain from infarction by regulating the blood flow to all parts of the brain, especially the cerebral region [149][150][151]. In normal conditions, SIRT1 has been reported to play a protective role by enhancing the nonamyloidogenic cleavage of amyloid-beta protein (APP) through NFkb inhibition.…”

Sirtuin functions in the brain: From physiological to pathological aspects

“…In mouse model of AD, Sirt1 reduces tau acetylation thus allowing ubiquitin ligases-mediated degradation of pathogenic phosphorylated tau (p-tau) [94] . A recent study has reported the decline in serum concentration of Sirt1 in AD patients, which provides an opportunity to develop Sirt1 as a predictive marker for AD [95] .…”